GNRH1 and cancer: Alternatives include ovarian tissue cryopreservation, which offers over 90% ovarian function recovery but risks cancer cell reimplantation, and GnRH agonists (GnRHa), which provide endocrine protection but are not yet standard due to potential complications [106].